FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3149413496> ?p ?o ?g. }

• W3149413496 endingPage "278" @default.
• W3149413496 startingPage "269" @default.
• W3149413496 abstract "The recommended maintenance dose of prasugrel for East Asian populations (i.e., Japanese and Taiwanese) is 3.75 mg as part of dual antiplatelet therapy (DAPT) for the prevention of recurrent ischemia and stent thrombosis in acute coronary syndrome (ACS). This modified dosage regimen has been established in studies conducted in Japan; however, the efficacy and safety of switching from clopidogrel to prasugrel DAPT among Taiwanese patients remain to be explored. In this phase IV, multicenter, single-arm, open-label study, we evaluated the 4-week pharmacodynamic response, and the 48-week safety outcomes of prasugrel 3.75 mg after a switch from clopidogrel in Taiwanese ACS patients. A total of 203 prasugrel-naïve ACS patients (over 90% male) who had received post-PCI clopidogrel DAPT for at least 2 weeks were enrolled from ten medical centers in Taiwan and subsequently switched to prasugrel 3.75 mg DAPT. Four weeks after the switch, P2Y12 reaction unit (PRU) values were significantly decreased in the total cohort (mean - 18.2 ± 48.1; 95% confidence interval - 24.9 to - 11.5, p < 0.001), and there was an overall consistent antiplatelet response in the treated subjects. The proportion of patients with high on-treatment platelet reactivity (HPR; PRU > 208) dropped from 23.5 to 10% (p < 0.001). Female sex was associated with a greater PRU reduction with prasugrel, whereas HPR at baseline, age ≥ 65 years, and body mass index ≥ 25 best predicted HPR at Week 4. Throughout the 48-week treatment with prasugrel, the incidences of MACE (1.0%) and TIMI major bleeding (2.0%) were rather low, accompanying an acceptable safety profile of TIMI minor (6.4%) and non-major, non-minor clinically relevant bleeding (3.0%). Overall, switching to the maintenance dose of prasugrel (3.75 mg) was observed to be effective and well tolerated among post-PCI ACS patients in Taiwan. Clinical Trial Registration Number: NCT03672097." @default.
• W3149413496 created "2021-04-13" @default.
• W3149413496 creator A5002692918 @default.
• W3149413496 creator A5005209999 @default.
• W3149413496 creator A5010643810 @default.
• W3149413496 creator A5022400812 @default.
• W3149413496 creator A5026729348 @default.
• W3149413496 creator A5033132506 @default.
• W3149413496 creator A5037234516 @default.
• W3149413496 creator A5038663112 @default.
• W3149413496 creator A5039415584 @default.
• W3149413496 creator A5040924502 @default.
• W3149413496 creator A5041539535 @default.
• W3149413496 creator A5041573283 @default.
• W3149413496 creator A5045822298 @default.
• W3149413496 creator A5050420171 @default.
• W3149413496 creator A5054093823 @default.
• W3149413496 creator A5062329309 @default.
• W3149413496 creator A5083449494 @default.
• W3149413496 creator A5087977831 @default.
• W3149413496 date "2021-04-04" @default.
• W3149413496 modified "2023-09-27" @default.
• W3149413496 title "Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy" @default.
• W3149413496 cites W1731676411 @default.
• W3149413496 cites W1923386888 @default.
• W3149413496 cites W1965299474 @default.
• W3149413496 cites W2017305007 @default.
• W3149413496 cites W2027373214 @default.
• W3149413496 cites W2046973755 @default.
• W3149413496 cites W2149011208 @default.
• W3149413496 cites W2161785946 @default.
• W3149413496 cites W2165637474 @default.
• W3149413496 cites W2169387542 @default.
• W3149413496 cites W2179201737 @default.
• W3149413496 cites W2501642025 @default.
• W3149413496 cites W2576695630 @default.
• W3149413496 cites W2748517697 @default.
• W3149413496 cites W2802159858 @default.
• W3149413496 cites W2925924778 @default.
• W3149413496 cites W2927414018 @default.
• W3149413496 cites W2940785957 @default.
• W3149413496 cites W2971992346 @default.
• W3149413496 cites W2973068166 @default.
• W3149413496 cites W2976166882 @default.
• W3149413496 cites W2991775063 @default.
• W3149413496 cites W3003059809 @default.
• W3149413496 cites W3024833356 @default.
• W3149413496 cites W3035351100 @default.
• W3149413496 cites W3043208190 @default.
• W3149413496 cites W3082881918 @default.
• W3149413496 cites W3131929894 @default.
• W3149413496 cites W3162195278 @default.
• W3149413496 cites W4205631876 @default.
• W3149413496 cites W2911870710 @default.
• W3149413496 doi "https://doi.org/10.1007/s12928-021-00771-w" @default.
• W3149413496 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34021881" @default.
• W3149413496 hasPublicationYear "2021" @default.
• W3149413496 type Work @default.
• W3149413496 sameAs 3149413496 @default.
• W3149413496 citedByCount "9" @default.
• W3149413496 countsByYear W31494134962022 @default.
• W3149413496 countsByYear W31494134962023 @default.
• W3149413496 crossrefType "journal-article" @default.
• W3149413496 hasAuthorship W3149413496A5002692918 @default.
• W3149413496 hasAuthorship W3149413496A5005209999 @default.
• W3149413496 hasAuthorship W3149413496A5010643810 @default.
• W3149413496 hasAuthorship W3149413496A5022400812 @default.
• W3149413496 hasAuthorship W3149413496A5026729348 @default.
• W3149413496 hasAuthorship W3149413496A5033132506 @default.
• W3149413496 hasAuthorship W3149413496A5037234516 @default.
• W3149413496 hasAuthorship W3149413496A5038663112 @default.
• W3149413496 hasAuthorship W3149413496A5039415584 @default.
• W3149413496 hasAuthorship W3149413496A5040924502 @default.
• W3149413496 hasAuthorship W3149413496A5041539535 @default.
• W3149413496 hasAuthorship W3149413496A5041573283 @default.
• W3149413496 hasAuthorship W3149413496A5045822298 @default.
• W3149413496 hasAuthorship W3149413496A5050420171 @default.
• W3149413496 hasAuthorship W3149413496A5054093823 @default.
• W3149413496 hasAuthorship W3149413496A5062329309 @default.
• W3149413496 hasAuthorship W3149413496A5083449494 @default.
• W3149413496 hasAuthorship W3149413496A5087977831 @default.
• W3149413496 hasBestOaLocation W31494134961 @default.
• W3149413496 hasConcept C126322002 @default.
• W3149413496 hasConcept C164705383 @default.
• W3149413496 hasConcept C2777028646 @default.
• W3149413496 hasConcept C2777628954 @default.
• W3149413496 hasConcept C2777698277 @default.
• W3149413496 hasConcept C2777849778 @default.
• W3149413496 hasConcept C2780400711 @default.
• W3149413496 hasConcept C27924281 @default.
• W3149413496 hasConcept C35294091 @default.
• W3149413496 hasConcept C45393284 @default.
• W3149413496 hasConcept C500558357 @default.
• W3149413496 hasConcept C71924100 @default.
• W3149413496 hasConceptScore W3149413496C126322002 @default.
• W3149413496 hasConceptScore W3149413496C164705383 @default.
• W3149413496 hasConceptScore W3149413496C2777028646 @default.
• W3149413496 hasConceptScore W3149413496C2777628954 @default.

• next